|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Adverum Biotechnologies, Inc (AAVL) |
|
|
$14.95 0.00 (0.00%) as of 4:30 Mon 3/25
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
44 |
|
|
|
Total
Direct Shares :
|
10,559,875 |
|
|
Total
Indirect Shares :
|
13,501,162 |
| |
%
Held by Insiders:
|
2.43% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Lupher, Jr. Mark L. |
|
2024-02-07 |
130,000 |
2024-02-07 |
0 |
| Scopa James Paul |
|
2024-02-07 |
100,000 |
2024-02-07 |
3,334 |
| Seyedkazemi Setareh |
Chief Development Officer |
2023-09-15 |
47,674 |
|
0 |
| Rubinstein Linda M |
Chief Financial Officer |
2023-06-07 |
100,000 |
2023-06-07 |
0 |
| Soparkar Peter |
Chief Operating Officer |
2023-03-15 |
265,891 |
2020-08-17 |
0 |
| Riley Brigit |
Chief Scientific Officer |
2023-03-15 |
117,435 |
|
0 |
| Fischer Laurent |
CEO, President and Director, Director |
2023-03-15 |
692,141 |
2020-08-17 |
0 |
| Beckman Richard |
Chief Medical Officer |
2022-09-19 |
39,061 |
2022-05-17 |
0 |
| Rakow John |
Officer |
2022-06-03 |
58,233 |
|
0 |
| Dsouza Rupert |
Chief Financial Officer |
2022-05-17 |
20,850 |
|
0 |
| Graham Dawn |
Director |
2022-05-16 |
50,000 |
2021-03-31 |
0 |
| Clark Julie |
Chief Medical Officer |
2021-09-30 |
164,723 |
|
0 |
| Thedinga Angela |
Chief Technology Officer |
2021-08-06 |
150,000 |
2021-08-06 |
0 |
| Machado Clarence Patrick |
Director |
2021-03-24 |
88,182 |
2017-03-14 |
0 |
| Patterson Leone D |
President and CFO |
2021-02-09 |
97,955 |
2016-06-15 |
0 |
| Woiwode Thomas |
Director |
2020-12-14 |
18,822 |
2016-05-11 |
0 |
| Gasmi Mehdi |
Director |
2020-07-20 |
274,442 |
2015-04-07 |
0 |
| Cheng Jennifer C. |
General Counsel |
2018-06-15 |
118,863 |
2018-06-15 |
0 |
| Carter Eric G |
Director |
2017-09-07 |
48,000 |
2017-09-07 |
0 |
| Countouriotis Athena |
SVP, Chief Medical Officer |
2017-06-19 |
150,000 |
2017-06-19 |
0 |
| Cleveland Paul B |
Chief Executive Officer, Director |
2017-06-12 |
22,727 |
2017-06-12 |
0 |
| Spivey Richard N. |
Director |
2017-06-12 |
70,804 |
2017-04-19 |
0 |
| Finer Mitchell H. |
Director |
2017-06-12 |
603,069 |
|
0 |
| Schwartz Steven Daniel |
Director |
2017-06-12 |
398,991 |
2014-08-05 |
0 |
| Salzman Amber |
President and CEO, Director |
2017-02-09 |
891,766 |
2016-05-11 |
0 |
| Barone Samuel B. |
SVP, Clinical Development |
2017-02-09 |
172,335 |
2015-04-21 |
0 |
| Wachter Paul |
Director |
2016-02-29 |
31,951 |
2016-02-29 |
37,161 |
| Mclaughlin John Peter |
Director |
2016-02-12 |
10,333 |
2016-02-12 |
26,560 |
| Rubio Roman G. |
SVP, Translational Medicine |
2016-02-12 |
165,650 |
2015-04-21 |
0 |
| Swartzburg Michael |
Principal Accounting Officer |
2016-02-12 |
82,113 |
2016-02-12 |
0 |
| Blumenkranz Mark S. |
Director |
2016-02-12 |
531,322 |
2016-02-12 |
31,593 |
| Braun Shirley |
VP, Human Resources |
2016-02-12 |
161,140 |
2015-09-21 |
0 |
| Hull Hans |
Chief Executive Officer |
2015-08-21 |
137,210 |
2014-08-05 |
0 |
| Bain Linda |
Chief Financial Officer |
2015-08-21 |
41,930 |
2015-04-21 |
0 |
| Chalberg Thomas W. |
Chief Executive Officer, Director |
2015-06-10 |
258,988 |
2015-06-10 |
840,413 |
| Guerin John Patrick Et Al |
Director, 10% Owner |
2015-05-27 |
0 |
2015-06-10 |
200,000 |
| Zygtech, Llc |
10% Owner |
2015-04-14 |
2,438,176 |
2014-08-05 |
0 |
| Regeneron Pharmaceuticals Inc |
10% Owner |
2014-08-05 |
1,809,098 |
2014-08-05 |
0 |
| Koh Bong Y |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
2,365,471 |
| Vhcp Management Ii, Llc |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
2,365,471 |
| Deerfield International Master Fund, L.p. |
Possible Members of 10% Group, 10% Owner |
2014-08-05 |
0 |
2014-08-05 |
627,267 |
| Russo Carlo |
|
|
0 |
|
0 |
| Osborne Aaron |
|
|
0 |
|
0 |
| Versant Capital Iv (switzerland) Gmbh |
10% Owner |
|
0 |
2016-05-11 |
7,003,892 |
|
|
